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ABSTRACT 
 
Introduction: The role of prenatal ultrasound in correctly identifying the level of the lesion in 
fetuses with open spina bifida has yet to be determined. The primary aim of this systematic review 
was to report the diagnostic accuracy of ultrasound in determining the level of the lesion in fetuses 
with open spina bifida. The secondary aim was to elucidate whether prenatal magnetic resonance 
imaging (MRI) improves the diagnostic performance of prenatal imaging in correctly identifying 
the level of the lesion. Material and methods: Inclusion criteria were studies reporting the 
agreement between ultrasound, MRI and postnatal or post-mortem assessment of fetuses with 
spina bifida. Agreement was defined as: complete (when the upper level of the lesion detected 
prenatally was the same recorded at postnatal or post-mortem evaluation), within one (when the 
upper level of the lesion recorded prenatally was within one vertebral body higher or lower than 
that reported postnatally) and within two vertebral bodies (when the upper level of the lesion 
recorded prenatally was within two vertebral bodies higher or lower than that reported postnatally 
or postmortem evaluation). Meta-analyses of proportions were used to combine 
data. Results: Fourteen studies (655 fetuses) were included. Ultrasound was able to identify the 
correct level of the lesion in 40.9% (95% CI 26.9-55.6) of cases. The upper level of the lesion 
recorded on ultrasound was within one vertebral body in 76.2% (95% CI 65.0-85.9) of cases, 
while within two segments in 92.4% (95% CI 84.3-97.7). Fetal MRI detected the exact level of the 
lesion in 42.5% (95% CI 35.9-45.2) of cases; the level of the lesion recorded on MRI was higher 
in 26.4% (95% CI 20.0-33.3) of cases and lower in 32.4% (95% CI 25.5-39.7) than that confirmed 
postnatally. The upper level of the lesion recorded on MRI was within one vertebral body in 
76.2% (95% CI 65.9-85.2) of cases, while within two segments in 94.2% (95% CI 90.2-97.2). 
Conclusions: Both ultrasound and MRI have a moderate diagnostic accuracy in identify the upper 
level of the lesion in fetuses with open spina bifida.  
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MRI magnetic resonance imaging
Key message: 
Both ultrasound and magnetic resonance imaging have a moderate diagnostic accuracy in 
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INTRODUCTION 
Spina bifida is among the most common congenital anomalies identified prenatally with a reported 
prevalence of around 0.5 per 1000 births. It is caused by an incomplete closure of the neural tube 
during embryonic life which leads to formation of a cleft in the vertebral column, with a 
corresponding defect in the skin so that the meninges and spinal cord are exposed. Spina bifida is 
also known as “open spinal dysraphism” or “spina bifida aperta” when the neural tissue is 
exposed, as opposed to “closed spinal dysraphism” or “spina bifida”, when the cleft in the 
vertebral column is not associated with a corresponding epithelial defect and the neural tissue is 
not exposed.1-3 
Prenatal diagnosis of spina bifida is fundamental as it allows referring these fetuses to 
centers with high expertise in surgical treatment of this conditions, and it also fundamental for an 
accurate prenatal counselling. Recently, the advances in prenatal imaging have led to significant 
improvement in the diagnostic accuracy of ultrasound in identifying these anomalies, with a 
reported detection rate of about 90% either by direct visualization of the spinal defect or the 
detection of the associated intra-cranial findings such as the lemon and banana signs.2,4-6 
Conversely, the diagnostic accuracy of ultrasound has been reported to be relatively poor for 
closed spinal defect mainly as the consequence of the lack of associated intracranial signs.2 
Prenatal diagnosis of open spina bifida is commonly accomplished during the second trimester of 
pregnancy, at the time of the anomaly scan, although first trimester diagnosis is widely reported in 
the published literature.3,7
Accurate identification of the level of the lesion in fetuses with spina bifida represents 
another fundamental issue also when assessing candidacy for open fetal surgery, while might 
potentially be  of less importance for fetoscopic repair, although this technique has not been 
validated in large randomized controlled trials yet.8,9  
Despite this, the role of prenatal ultrasound in correctly identifying the level of the lesion 
in fetuses with open spina bifida has yet to be determined. Fetal magnetic resonance imaging 
(MRI) has been reported to provide additional information in fetuses with brain anomalies not 
detected on ultrasound and is commonly performed to confirm the diagnosis, to rule out any 
additional malformations, and predict the prognosis.10-11 However, it is not known whether MRI 
truly improves the diagnostic accuracy of ultrasound in correctly identifying the level of the lesion 
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The aim of this systematic review was to explore the diagnostic performance of prenatal 
ultrasound and MRI in determining the level of the lesion in fetuses with open spina bifida.
MATERIAL AND METHODS 
Protocol, eligibility criteria, information sources and search 
This review was performed according to an a-priori designed protocol and recommended for 
systematic reviews and meta-analysis.13 Medline and Embase databases were searched 
electronically on January 2020 utilizing combinations of the relevant medical subject heading 
(MeSH) terms, key words, and word variants for “spina bifida”, “neural tube defects”, 
“ultrasound” and “magnetic resonance imaging”. The search and selection criteria were restricted 
to English language. Reference lists of relevant articles and reviews were hand searched for 
additional reports. Prisma guidelines were followed.14-15  
 
Outcomes explored, study selection, data collection and data items 
The primary aim of the study was to elucidate the diagnostic accuracy of prenatal ultrasound 
(either 2D or 3D) in correctly identifying the level of the lesion in fetuses with open spina bifida. 
The reference standard was postnatal assessment either by imaging techniques (X-ray or MRI) or 
findings at autopsy (post-mortem assessment).
For the purpose of the analysis, agreement between ultrasound and post-natal or post-mortem 
assessment was defined as:
 Complete, when the upper level of the lesion on ultrasound was the same recorded at 
postnatal or post-mortem evaluation.
 Within one vertebral body, when the upper level of the lesion recorded on ultrasound was 
within one vertebral body higher or lower than that reported postnatally.
 Within two vertebral bodies, when the upper level of the lesion recorded on ultrasound was 
within two vertebral bodies higher or lower than that reported postnatally.
Furthermore, we explore the discrepancy between the level of the lesion recorded on ultrasound 
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according to the type of ultrasound technique adopted (2D or 3D) and the time of ultrasound 
assessment (including only studies from the last decade) were also performed.
The secondary aim was to elucidate the diagnostic accuracy of fetal MRI in correctly 
identifying the level of the lesion in fetuses with open spina bifida. 
Only studies reporting the diagnostic accuracy of either ultrasound or MRI in detecting the 
level of the lesion in fetuses with open spina bifida were considered suitable for the inclusion in 
the current systematic review. Postnatal studies or studies from which cases diagnosed prenatally 
could not be extracted were excluded. Paediatric and surgical series including only symptomatic 
cases or patients undergoing surgical treatment not reporting information on the observed 
outcomes were also excluded. Studies of published before 2000 were also excluded, as we 
considered that advances in prenatal imaging techniques, improvements in the diagnosis 
and definition of this anomaly make these less relevant. 
Only full text articles were considered eligible for the inclusion; case reports, conference 
abstracts and case series with fewer than 5 cases of spina bifida were also excluded in order to 
avoid publication bias. 
Two authors (FG, FDA) reviewed all abstracts independently. Agreement regarding 
potential relevance was reached by consensus. Full text copies of those papers were obtained, and 
the same two reviewers independently extracted relevant data regarding study characteristics and 
pregnancy outcome. Inconsistencies were discussed by the reviewers and consensus reached or by 
discussion with a third author. If more than one study was published for the same cohort with 
identical endpoints, the report containing the most comprehensive information on the population 
was included to avoid overlapping populations. 
Quality assessment and risk of bias 
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale 
(NOS) for cohort studies. According to NOS, each study is judged on three broad perspectives: the 
selection of the study groups; the comparability of the groups; and the ascertainment outcome of 
interest .16 Assessment of the selection of a study includes the evaluation of the representativeness 
of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that outcome of interest was not present at start of study. Assessment of the 
comparability of the study includes the evaluation of the comparability of cohorts on the basis of 
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of the type of the assessment of the outcome of interest, length and adequacy of follow-
up (Wells).16 According to NOS a study can be awarded a maximum of one star for each 
numbered item within the Selection and Outcome categories. A maximum of two stars can be 
given for Comparability.16  
Statistical analyses 
We used meta-analyses of proportions were used to combine data. Funnel plots displaying the 
outcome rate from individual studies versus their precision (1/standard error) were carried out with 
an exploratory aim. Tests for funnel plot asymmetry were not used when the total number of 
publications included for each outcome was less than ten. In this case, the power of the tests is too 
low to distinguish chance from real asymmetry. Between-study heterogeneity was explored using 
the I2 statistic, which represents the percentage of between-study variation that is due to 
heterogeneity rather than chance. A value of 0% indicates no observed heterogeneity, whereas 
I2 values of ≥ 50% indicate a substantial level of heterogeneity.17-20 All analyses were performed 
using Stata version 13.1 (Stata Corp., College Station, TX, USA). 
RESULTS 
Study selection and characteristics 
243 articles were identified, 61 were assessed with respect to their eligibility for inclusion and 14 
studies including 655 fetuses affected by spina bifida were included in the systematic review 
(Table 1, Supporting Information Tables S1-S2, Figure 1).21-34 
The results of the quality assessment of the included studies using NOS are presented in 
Table 2. Most of the included studies showed an overall good score regarding the selection and 
comparability of the study groups, and for ascertainment of the outcome of interest. The main 
weaknesses of these studies were their retrospective design, small sample size, heterogeneity of in 
gestational age at assessment, protocols for antenatal detection of the level of the lesion and 
ultrasound technique adopted.










This article is protected by copyright. All rights reserved
Ten23-32 (452 fetuses) reported the accuracy of ultrasound in identifying the level of the lesion in 
fetuses with open spina bifida. Overall, ultrasound was able to identify the correct level of the 
lesion in 40.9% (95% CI 26.9-55.6;193/452 fetuses) of cases; in 31.7% (95% CI 11.9-55.8; 
57/233) the level of the lesion recorded on ultrasound was higher, while in 25.7% (95% CI 10.5-
44.8; 81/233) lower than that recorded after birth or at autopsy (Table 3).
The upper level of the lesion recorded on ultrasound was within one vertebral body in 76.2% (95% 
CI 65.0-85.9; 359/468), while within two segments in 92.4% (95% CI 84.3-97.7; 397/434) of 
cases. 
The discrepancy between the upper level of the lesion detected on ultrasound and that at 
postnatal assessment or autopsy was one vertebral body in 34.3% (95% CI 25.2-43.9; 155/434) of 
cases, while the corresponding figures for two, three and  four vertebral bodies were 20.5% (95% 
CI 8.2-36.6; 90/467), 4.3% (95% CI 1.4-8.7; 22/467) and 2.4% (95% CI 0.03-6.2; 8/173) 
respectively (Table 3). 
Sub-group analyses according to the type of ultrasound technique adopted (2D or 3D) are 
reported in Tables 4 and 5. Overall, 2D ultrasound correctly identifying the upper level of the 
lesion in 36.0% (95% CI 24.0-49.0; 155/404), while the agreement was within one in 71.8% (95% 
CI 63.8-79.2; 311/420) and within two vertebral bodies in 90.7% (95% CI 81.6-97.0). The level of 
the lesion recorded on ultrasound was higher in 36.2% (95% CI 12.0-64.9; 52/185) and lower in 
29.1% (95% CI 12.5-49.0) than that confirmed postnatally or postmortem (Table 4).
Only three studies23,25,32 (157 fetuses) explored the diagnostic accuracy of 3D ultrasound in 
identifying the level of the lesion in fetuses with open spina bifida. There was a complete 
agreement between 3D ultrasound and postnatal assessment in 67.1% (95% CI 43.7-86.7; 95/157) 
of cases, while the discrepancy between pre and postnatal assessment was within one vertebral 
body in 94.6% (95% CI 75.4-99.8; 139/157) and within two in 96.2% (95% CI 85.3-99.9) (Table 
5).
Finally, when considering only studies published in the last decade, there was complete 
agreement between the upper level of the lesion described on ultrasound and postnatal or post-
mortem assessment in 43.7% (95% CI 25.0-63.3; 147/302) of cases, while the agreement was 
within one and two vertebral bodies in 78.9% (95% CI 58.8-93.5; 194/250) and 51.3% (95% CI 
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Five studies22,28,29,31,34 (210 fetuses) reported the agreement between fetal MRI and postnatal or 
post-mortem assessment for the detection of the upper level of the lesion in fetuses with open 
spina bifida diagnosed prenatally. Overall, fetal MRI detected the exact level of the lesion in 
42.5% (95% CI 35.9-45.2; 89/210) of cases; the level of the lesion recorded on MRI was higher in 
26.4% (95% CI 20.0-33.3; 43/165) and lower in 32.4% (95% CI 25.5-39.7; 53/165) than that 
confirmed postnatally or at autopsy (Table 6).
The upper level of the lesion recorded on MRI was within one vertebral body in 76.2% 
(95% CI 65.9-85.2; 162/207) of cases, while within two segments in 94.2% (95% CI 90.2-97.2; 
164/173). 
The discrepancy between the upper level of the lesion detected on ultrasound and that at 
postnatal assessment or autopsy was one vertebral body in 40.7% (95% CI 33.5-40.8; 70/173) of 
cases, two in 13.4% (95% CI 8.8-19.9; 22/73), three in 5.3% (95% CI 2.5-9.1; 8/173), while in 
none of the included cases there was a discrepancy of  four vertebral bodies (Table 6). 
DISCUSSION 
The findings from this systematic review showed that ultrasound has a moderate diagnostic 
accuracy in correctly identifying the upper level of the lesion in fetuses with open spina bifida. 
The agreement between ultrasound and postnatal or post-mortem was within one vertebral body in 
76% and two vertebral bodies in 76% and within two in 92% of cases respectively. Although a 
direct comparison between the two techniques was not possible, the level of agreement between 
fetal MRI and postnatal assessment was similar to that reported on ultrasound. Finally, 3D 
ultrasound was associated with a higher rate of agreement compared to 2D ultrasound, although 
the small number of included cases limited the robustness of the analysis. 
This is to our knowledge the first systematic review reporting the diagnostic accuracy of 
prenatal imaging in correctly identifying the level of the lesion in fetuses with open spina bifida. 
Thorough literature search and the multitude of outcomes explored represent the main strengths of 
the present systematic review. Small number of included studies, heterogeneity in gestational age 
at assessment, as well as the ultrasound technique and reference standard adopted for confirming 
the level of the lesion after birth or at post-mortem examination represent the main weakness of 
the present systematic review. Furthermore, the included studies did not differentiate between the 
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MRI was not reported in a blinded assessment in the original studies, thus making not possible to 
extrapolate a robust evidence on the actual role of MRI in prenatal assessment of fetuses with 
spina bifida.
It is widely known that the level of the lesion in spina bifida strongly influences the 
prognosis. According to the lesion level, the newborn can have difficulties in walking, sensory 
deficiency, motor deficiency and also incontinence problems, low school performance, and then in 
adulthood respiratory and cardiac problems.8,35-38 Children with lower level lesions are more likely 
to walk than those with higher level lesions. Moreover, the level and the extent of the defect are 
usually considered among the major predictors of the ability to walk, with quadriplegia often 
arising from cervical lesions and paraplegia mostly associated with thoracic and lumbosacral 
lesions.8,39-41 
In view of this association, prenatal counselling of parents whose pregnancy is complicated by 
fetal spina bifida should explore the potential limitations of ultrasound in identifying the level of 
the lesion. 
The findings from this meta-analysis showed that ultrasound has an overall moderate 
agreement in identifying the level of the lesion in fetuses with spina bifida aperta. Despite this, 
assessment of the level of the lesion on ultrasound has not been standardized yet and there is still 
large heterogeneity among different centers in the diagnostic criteria used to determine the level of 
the lesion, such as the most cephalic vertebra with evidence of laminar separation31 or the first 
vertebra showing widening of the ossification centers.30 Many authors also considered T12 as the 
insertion of the most caudal rib and the iliac crests as a landmark to locate L5 level.44 Identifying 
conus medullaris might be also helpful during spinal examination, as it usually ends at L4 level 
between 13 and 18 weeks and then tends to migrate, so it may often be recognized at L3 between 
19 and 36 weeks and at L2 after 36 weeks of gestation.42 The detection rate of spina bifida in 
second trimester routine ultrasound in nowadays very high, mostly because the examination of the 
spine has become mandatory and a longitudinal scan of the fetal spine should always also be 
obtained also during a basic assessment.43 Moreover, the development of 3D ultrasonography 
brought new possibilities to early diagnosis: 3D ultrasound allows to identify the whole spine and 
to examine images in sections and in different planes at the same time. Furthermore, in the past 
few years the use of antenatal MRI has significantly expanded in many fields of maternal and fetal 
medicine,11,44-45 but the most important role remains the evaluation of fetal nervous system:12,46 
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was similar for MRI and ultrasound. Fetal MRI is frequently performed as a secondary imaging 
tool to assess neural tube defects, rule out additional central nervous system (CNS) and non-CNS 
anomalies, and influence management decision.47
Finally, a proper identification of the topography of the lesion is also pivotal for 
preoperative assessment in case of intrauterine surgery. In fact, fetal therapy is offered only to 
fetuses affected by myelomeningocele with the upper boundary located between T1 and S1 and 
evidence of hindbrain herniation in the only randomized controlled trial (RCT) published so far 
comparing prenatal versus postnatal repair of the spina bifida.9 In this trial, prenatal surgery 
significantly reduced the need for cerebrospinal fluid shunt placement during the first year of life, 
improved psychomotor development at 30 months of age, and increased chances of independent 
ambulation at 30 months compared with those who underwent postnatal repair.9,48-50 However, the 
primary outcome of the study - the need for shunt placement - is subjective and open to the biases 
of the individual neurosurgeons caring for the infant. 
Finally, prenatal procedure might be often complicated by preterm birth, oligohydramnios, 
spontaneous membrane rupture, placental abruption, pulmonary edema and higher incidence of 
uterine dehiscence of the hysterotomy site9 and therefore minimally invasive strategies, such as 
fetoscopic approach, have been proposed to reduce open surgery risks,51 but further RCTs are 
needed to assess their real efficacy.
CONCLUSION
Ultrasound has an overall good accuracy in identifying the anatomical level of the lesion in fetuses 
with open spina bifida. The findings from this systematic review can improve prenatal counselling 
of parents whose pregnancy is complicated by open fetal spina bifida. 
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Figure 1. Prisma flow diagram.
Supporting Information legends
Table S1. Excluded studies and reason for the exclusion.
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Table 1. General Characteristics of the included studies.











Sherrod20 2019 United States Retrospective 2013-2018 23.0 ± 4.7 (US); 
24.0 ± 4.1 (MRI)
US, MRI Surgery 34
Nagaraj21 2018 United States Retrospective 2004-2016 23.9+/- 3.6w MRI MRI 119
Requeijo22 2016 Brazil Prospective 2004-2013 27.1 (18–38)w 2D-3D US X-ray 50
Carreras23 2016 Spain Observational 2011-2015 18-26 2D Surgery 18




Aguilera25 2009 United 
Kingdom







Retrospective 1997-2007 27.5 (18–42) 2D US  MRI 58





Appasamy28 2006 United 
Kingdom





Bruner29 2004 USA Retrospective 1997-2003 23(17+6 to 28+6) 2D US X-ray, 
MRI
111
Aaronson30 2003 United States Prospective 1997-2002 21-29 US, MRI MRI, X-
ray
100
Lee31 2002 United States Retrospective NS 21.8w ± 
3.4(2DUS) , 22.8 
± 4.4(3D US) 
2D-3D US  MRI, X-
ray
9
Biggio32 2001 United 
Kingdom
Retrospective 1996-2000 21 ± 4.9 2D US X-ray, 
surgery
33
Mangels33 2000 United States Retrospective NS 19.5-27.4 (range) MRI MRI 37
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Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) 
for cohort studies; a study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for Comparability.
Author Year Selection Comparability Outcome
Sherrod20 2019   
Nagaraj21 2018   
Requeijo22 2016   
Carreras23 2016   
Buyukkurt24 2012   
Aguilera25 2009   
Van Der 
Vossen26
2009   
Saleem27 2009   
Appasamy28 2006   
Bruner29 2004   
Aaronson30 2003   
Lee31 2002   
Biggio32 2001   
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Table 3. Pooled proportions (95% CI) showing the rate of agreement between ultrasound (either 







I2 Pooled proportions 
(95% CI)
Same level than post-natal 10 22-31 193/452 42.70 (38.1-47.4) 88.8 40.86 (26.9-55.6)
US higher than post-natal 7 23-26, 28, 30-31 57/233 24.46 (19.1-30.5) 92.4 31.71 (11.9-55.8)
US lower than post-natal 7 23-26, 28, 30-31 81/233 34.76 (28.7-41.3) 88.6 25.71 (10.5-44.8)
Within one level 10 20, 22-24, 26-31 359/468 76.71 (72.6-80.5) 84.5 76.24 (65.0-85.9)
Within two levels 9 22-24, 26-31 397/434 91.47 (88.4-93.9) 83.7 92.38 (84.3-97.7)
One level than post-natal 9 22-24, 26-31 155/434 35.71 (31.2-40.4) 72.3 34.28 (25.2-43.9)
One level higher than post-natal 7 22-24, 26, 28, 30-31 48/315 15.24 811.5-19.7) 53.3 16.10 (10.2-23.1)
One level lower than post-natal 7 22-24, 26, 28, 30-31 57/315 18.10 (14.0-22.8) 72.8 17.45 (13.5-21.8)
Two levels than post-natal 9 22-24, 26-31 90/467 19.27 (15.8-23.1) 92.9 20.49 (8.2-36.6)
Two levels higher than post-
natal
6 23-24, 26, 28, 30-31 10/215 4.65 (2.3-8.4) 71.2 5.88 (1.2-13.8)
two levels lower than post-natal 6 23-24, 26, 28, 30-31 22/215 10.23 (6.5-15.1) 76.0 8.54 (2.2-18.5)
Three levels than post-natal 9 22-24, 26-31 22/467 4.71 (3.0-7.0) 70.2 4.31 (1.4-8.7)
Three levels higher than post-
natal
6 23-24, 26, 28, 30-31 3/215 1.40 (0.3-4.0) 23.1 1.72 (0.3-4.4)
Three levels lower than post-
natal
6 23-24, 26, 28, 30-31 5/215 2.33 (0.8-5.3) 1.6 2.61 (0.9-5.2)
Four or more levels than post-
natal
9 22-24, 26-31 12/467 2.57 (1.3-4.4) 73.7 2.40 (0.03-6.2)
Four or more levels higher than 
post-natal
6 23-24, 26, 28, 30-31 5/215 2.33 (0.8-5.3) 61.0 2.68 (0.2-7.7)
Four or more levels lower than 
post-natal
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Table 4. Pooled proportions (95% CI) showing the rate of agreement between 2D ultrasound and 







I2 Pooled proportions 
(95% CI) 
Same level than post-natal 9 22-23, 25-31 155/404 38.37 (33.6-43.3) 83.3 36.01 (24.0-49.0) 
US higher than post-natal 6 23, 25-26, 28, 30-
31 
52/185 28.11 (21.9-35.3) 93 36.15 (12.0-64.9) 
US lower than post-natal 6 23, 25-26, 28, 30-
31 
76/185 41.08 (34.0-48.5) 85.7 29.02 (12.5-49.0) 
       
Within one level 9 20, 22-23, 26-31 311/420 74.05 (69.5-78.1) 61.4 71.83 (63.8-79.2) 
Within two levels 8 22-23, 26-31 349/386 90.41 (86.9-93.1) 82.9 90.72 (81.6-97.0) 
       
One level than post-natal 8 22-23, 26-31 145/386 37.56 (32.7-42.6) 70.4 36.38 (26.8-46.6) 
One level higher than post-natal 6 22-23, 26, 28, 30-
31 
43/267 16.1 (12.0-21.2) 58.5 17.33 (10.2-25.9) 
One level lower than post-natal 6 22-23, 26, 28, 30-
31 
52/267 19.48 (15.0-24.8) 75.3 15.36 /7.0-26.2) 
       
Two levels than post-natal 9 22-23, 26-32 90/419 21.48 (17.7-25-8) 91.8 24.45 (11.0-41.3) 
Two levels higher than post-natal 5 23, 26, 28, 30-31 10/167 5.99 (3.1-11.0) 69.9 8.14 (1.8-18.5) 
two levels lower than post-natal 5 23, 26, 28, 30-31 22/167 13.17 (8.6-19.5) 44.7 12.23 (5.9-20.5) 
       
Three levels than post-natal 9 22-23, 26-32 22/419 5.25 (3.4-8.0) 70.0 5.08 (1.7-10.2) 
Three levels higher than post-natal 5 23, 26, 28, 30-31 3/167 1.8 (0.5-5.6) 31.2 2.34 (0.3-6.3) 
Three levels lower than post-natal 5 23, 26, 28, 30-31 5/167 2.99 (1.1-7.2) 0 3.50 (1.3-6.8) 
       
Four or more levels than post-natal 9 22-23, 26-32 12/419 2.86 (1.6-5.1) 76.2 2.79 (0.6-5.2) 
Four or more levels higher than 
post-natal 
5 23, 26, 28, 30-31 5/167 2.99 (1.1-7.2) 66.1 2.35 (0.2-11.0) 
Four or more levels lower than 
post-natal 
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Table 5. Pooled proportions (95% CI) showing the rate of agreement between 3D ultrasound and 
postnatal or postmortem assessment. 
 Studies 
(n) 
References Fetuses (n) Raw proportions 
(95% CI) 
I2 Pooled proportions 
(95% CI) 
Same level than post-natal 3 22, 24, 31 95/157 60.5 (52.4-68.1) 84.7 67.14 (43.7-86.7) 
US higher than post-natal 2 24, 31 6/57 3.82 (1.6-8.5) 0 11.71 (4.8-21.2) 
US lower than post-natal 2 24, 31 6/57 3.82 (1.6-8.5) 0 11.71 (4.8-21.2) 
       
Within one level 3 22, 24, 31 139/157 88.54 (82.2-92.9) 89.4 94.59 (75.4-99.8) 
Within two levels 3 22, 24, 31 147/157 93.63 (88.3-96.7) 77.4 96.17 (85.3-99.9) 
       
One level than post-natal 3 22, 24, 31 44/157 28.03 (21.3-35.8) 0.5 28.28 (21.5-35.6) 
One level higher than post-
natal 
3 22, 24, 31 18/157 11.46 (7.1-17.8) 0 12.14 (7.5-17.7) 
One level lower than post-
natal 
3 22, 24, 31 26/157 16.56 (11.3-23.5) 5.6 16.80 (11.1-23.4) 
       
Two levels than post-natal 3 22, 24, 31 8/157 5.10 (2.4-10.1) 69.8 3.40 (0.001-12.1) 
Two levels higher than post-
natal 
-  - - - - 
two levels lower than post-
natal 
-  - - -  
-       
Three levels than post-
natal 
3 22, 24, 31 10/157 6.37 (3.3-11.7) 77.4 3.83 (6.3-14.7) 
Three levels higher than 
post-natal 
-  - - - - 
Three levels lower than 
post-natal 
-  - - - - 
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post-natal 
Four or more levels higher 
than post-natal 
3 22, 24, 31 0/157 0 (0-3.0) 0 0 (0-2.0) 
Four or more levels lower 
than post-natal 
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Table 6. Pooled proportions (95% CI) showing the rate of agreement between fetal magnetic 
resonance imaging (MRI) and postnatal or postmortem assessment.
Studies 
(n)





Same level than post-natal 5 21, 27, 28, 30, 33 89/210 42.38 (35.6-49.4) 0 42.50 (35.9-49.2)
MRI higher than post-natal 3 21, 28, 30 43/165 26.06 (19.5-33.5) 0 26.41 (20.0-33.3)
MRI lower than post-natal 3 21, 28, 30 53/165 32.12 (25.1-39.8) 0 32.37 (25.5-39.7)
Within one level 5 20.21, 27, 28, 30 162/207 78.26 (72.0-83.7) 49.4 76.21 (65.9-85.2)
Within two levels 4 21, 27, 28, 30 164/173 94.80 (90.4-97.6) 0 94.18 (90.2-97.2)
One level than post-natal 4 21, 27, 28, 30 70/173 40.46 (33.1-48.2) 0 40.65 (33.5-48.0)
One level higher than post-
natal
2 28, 30 11/46 23.91 (12.6-38.8) 0 24.85 (13.7-38.1)
One level lower than post-
natal
2 28, 30 9/46 19.57 (9.4-33.9) 0 20.74 (10.5-33.4)
Two levels than post-natal 4 21, 27, 28, 30 22/173 12.72 (8.1-18.6) 0 13.43 (8.8-19.9)
Two levels higher than post-
natal
2 28, 30 3/46 6.52 (1.4-17.9) 0 7.84 (2.0-17.1)
two levels lower than post-
natal
2 28, 30 4/46 8.70 (2.4-20.8) 0 9.55 (2.9-19.5)
Three levels than post-natal 4 21, 27, 28, 30 8/173 4.62 (2.0-8.9) 0 5.28 (2.5-9.1)
Three levels higher than post-
natal
2 28, 30 0/46 0 (0-7.1) 0 0 (0-5.6)
Three levels lower than post-
natal
2 28, 30 1/46 2.17 (0.01-11.5) 0 3.57 (0.2-10.7)
Four or more levels than post-
natal
4 21, 27, 28, 30 0/173 0 (0-2.1) 0 0 (0-19.3)
Four or more levels higher 
than post-natal
2 28, 30 0/46 0 (0-7.1) 0 0 (0-5.6)
Four or more levels lower 
than post-natal
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